{"schema_version":"1","generated_at":"2026-11-03T06:16:54.904Z","data_as_of":null,"url":"https://www.findmykol.com/kol/drew-kurtzman","json_url":"https://www.findmykol.com/kol/drew-kurtzman/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"drew-kurtzman","name":"Drew Kurtzman","credential":"MD","specialty":"Dermatology","specialty_raw":"Dermatology","therapeutic_area":"Dermatology","therapeutic_areas":["Dermatology"],"institution":"Wright State University","institution_url":"https://www.findmykol.com/institution/wright-state-university","city":"Highland Heights","state":"KY","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1992086102","orcid":"0000-0002-9192-4465","openalex":"A5011755909"},"summary":"Drew Kurtzman is a Dermatology physician affiliated with Wright State University. OpenAlex indexes 49 publications with 1,097 citations (h-index 15).","overview":null,"focus":{"indications":[],"research_topics":["Dermatology"]},"scholarship":{"works_count":49,"cited_by_count":1097,"h_index":15,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":19,"program_years":{"first":2021,"last":null},"rows_total":45,"shown":3,"withheld":42,"rows":[{"payer":"Regeneron Healthcare Solutions, Inc.","program_year":2025,"amount_usd":30.67,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1992086102"},{"payer":"PFIZER INC.","program_year":2025,"amount_usd":19.64,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1992086102"},{"payer":"Amgen Inc.","program_year":2025,"amount_usd":19.21,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1992086102"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1992086102","source":"payments"},"prescribing":{"data_year":2024,"areas_total":8,"areas_shown":3,"areas":[{"area":"Cancer & immunology","share_pct":28.4,"classes_total":6,"classes":[{"class":"Nucleoside Metabolic Inhibitor","setting":"prescribed","share_pct":8.7,"drugs":[{"name":"Fluorouracil","share_pct":100}],"max_beneficiaries":66},{"class":"Folate Analog Metabolic Inhibitor","setting":"prescribed","share_pct":7,"drugs":[{"name":"Methotrexate","share_pct":100}],"max_beneficiaries":15}]},{"area":"Dermatology","share_pct":23,"classes_total":3,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":13.8,"drugs":[{"name":"Triamcinolone Acetonide","share_pct":100}],"max_beneficiaries":69},{"class":"Interleukin-4 Receptor alpha Antagonist","setting":"prescribed","share_pct":7.6,"drugs":[{"name":"Dupixent Syringe","share_pct":63.3},{"name":"Dupixent Pen","share_pct":36.7}],"max_beneficiaries":null}]},{"area":"Sensory organs","share_pct":20.4,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":20.4,"drugs":[{"name":"Clobetasol Propionate","share_pct":47.2},{"name":"Hydrocortisone","share_pct":46},{"name":"Betamethasone Diprop Augmented","share_pct":6.8}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":100,"facility_pct":0},"source":"medicare"},"publications":{"total":44,"shown":5,"withheld":39,"matched_by":"OpenAlex author record","recent":[{"title":"A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies","year":2021,"journal":"Lara D. Veeken","source_url":"https://doi.org/10.1093/rheumatology/keab166","status":"verified"},{"title":"Corrigendum to: A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies","year":2021,"journal":"Lara D. Veeken","source_url":"https://doi.org/10.1093/rheumatology/keab616","status":"verified"},{"title":"Wellness, burnout, and the dermatologist: Fundamentals for practice longevity","year":2020,"journal":"Clinics in Dermatology","source_url":"https://doi.org/10.1016/j.clindermatol.2020.02.010","status":"verified"},{"title":"A systematic review and meta-analysis of the efficacy and safety of the interleukin (IL)-12/23 and IL-17 inhibitors ustekinumab, secukinumab, ixekizumab, brodalumab, guselkumab and tildrakizumab for the treatment of moderate to severe plaque psoriasis","year":2018,"journal":"Journal of Dermatological Treatment","source_url":"https://doi.org/10.1080/09546634.2017.1422591","status":"verified"},{"title":"The 100 top‐cited publications in psoriatic arthritis: a bibliometric analysis","year":2018,"journal":"International Journal of Dermatology","source_url":"https://doi.org/10.1111/ijd.14261","status":"verified"}],"source":"works"},"contact":{"address_1":"2626 ALEXANDRIA PIKE","city":"Highland Heights","state":"KY","zip":"410761530","phone":"859-371-3376","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1992086102","source":"identity"},"similar":[{"name":"Craig Rohan","slug":"craig-rohan","institution":"Wright State University","specialty":"Dermatology","url":"https://www.findmykol.com/kol/craig-rohan","json_url":"https://www.findmykol.com/kol/craig-rohan/profile.json"},{"name":"John Fleishman","slug":"john-fleishman","institution":"Wright State University","specialty":"Ophthalmology","url":"https://www.findmykol.com/kol/john-fleishman","json_url":"https://www.findmykol.com/kol/john-fleishman/profile.json"},{"name":"Douglas Lehrer","slug":"douglas-lehrer","institution":"Wright State University","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/douglas-lehrer","json_url":"https://www.findmykol.com/kol/douglas-lehrer/profile.json"},{"name":"Lionel Chow","slug":"lionel-chow","institution":"Wright State University","specialty":"Pediatric Hematology-Oncology","url":"https://www.findmykol.com/kol/lionel-chow","json_url":"https://www.findmykol.com/kol/lionel-chow/profile.json"},{"name":"Robert Modlin","slug":"robert-modlin","institution":"University of California, Los Angeles","specialty":"Dermatology","url":"https://www.findmykol.com/kol/robert-modlin","json_url":"https://www.findmykol.com/kol/robert-modlin/profile.json"},{"name":"Heidi Kong","slug":"heidi-kong","institution":"National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)","specialty":"Dermatology","url":"https://www.findmykol.com/kol/heidi-kong","json_url":"https://www.findmykol.com/kol/heidi-kong/profile.json"},{"name":"Jon Hanifin","slug":"jon-hanifin","institution":"Oregon Health & Science University (OHSU)","specialty":"Dermatology","url":"https://www.findmykol.com/kol/jon-hanifin","json_url":"https://www.findmykol.com/kol/jon-hanifin/profile.json"},{"name":"Victoria Werth","slug":"victoria-werth","institution":"Perelman School of Medicine at the University of Pennsylvania","specialty":"Dermatology","url":"https://www.findmykol.com/kol/victoria-werth","json_url":"https://www.findmykol.com/kol/victoria-werth/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":42,"publications":39}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2026-01-27","provider_certified":"2026-01-27","collected_at":"2026-11-03T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}